| Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A SBIR Phase II contract was awarded to NeuroCog Trials in March, 2018 for $1,428,992.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4R44AG058345-02 | Phase II | 1,428,992 | March 15, 2018 | |||||||
| A SBIR Phase I contract was awarded to NeuroCog Trials in September, 2017 for $215,399.0 USD from the U.S. Department of Health & Human Services. | SBIR | 4R44AG058345-02 | Phase I | 215,399 | September 15, 2017 | |||||||
| A SBIR Phase II contract was awarded to NeuroCog Trials in May, 2016 for $1,371,357.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44AG053121-01 | Phase II | 1,371,357 | May 15, 2016 | |||||||
| A SBIR Phase II contract was awarded to NeuroCog Trials in August, 2016 for $2,265,704.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44MH084240-04 | Phase II | 2,265,704 | August 1, 2016 | |||||||
| A SBIR Phase II contract was awarded to NeuroCog Trials for $1,152,894.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44MH084240-02 | Phase II | 1,152,894 | ||||||||
| A SBIR Phase I contract was awarded to NeuroCog Trials for $137,176.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43MH084240-01A2 | Phase I | 137,176 |